176 related articles for article (PubMed ID: 31199826)
1. Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis.
Akahane T; Yamaguchi T; Kato Y; Yokoyama S; Hamada T; Nishida Y; Higashi M; Nishihara H; Suzuki S; Ueno S; Tanimoto A
PLoS One; 2019; 14(6):e0217724. PubMed ID: 31199826
[TBL] [Abstract][Full Text] [Related]
2. Direct next-generation sequencing analysis using endometrial liquid-based cytology specimens for rapid cancer genomic profiling.
Akahane T; Kitazono I; Kobayashi Y; Nishida-Kirita Y; Yamaguchi T; Yanazume S; Tabata K; Kobayashi H; Tanimoto A
Diagn Cytopathol; 2021 Sep; 49(9):1078-1085. PubMed ID: 34319014
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
Akahane T; Kitazono I; Yanazume S; Kamio M; Togami S; Sakamoto I; Nohara S; Yokoyama S; Kobayashi H; Hiraki T; Suzuki S; Ueno S; Tanimoto A
BMC Med Genomics; 2020 Jul; 13(1):101. PubMed ID: 32652986
[TBL] [Abstract][Full Text] [Related]
4. Performance of a 50-gene next generation sequencing panel with post-centrifuge supernatant cytology fluid in non-small-cell lung cancer.
Tafoya M; Judd A; Chiotti K; Dearen K; Jiron K; Chabot-Richards D; Broehm CJ
Diagn Cytopathol; 2021 Nov; 49(11):1173-1178. PubMed ID: 34339108
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
Yamaguchi T; Akahane T; Harada O; Kato Y; Aimono E; Takei H; Tasaki T; Noguchi H; Nishihara H; Kamata H; Tanimoto A
Diagn Cytopathol; 2020 Nov; 48(11):965-971. PubMed ID: 32511899
[TBL] [Abstract][Full Text] [Related]
6. Reducing DNA damage by formaldehyde in liquid-based cytology preservation solutions to enable the molecular testing of lung cancer specimens.
Matsuo Y; Yoshida T; Yamashita K; Satoh Y
Cancer Cytopathol; 2018 Dec; 126(12):1011-1021. PubMed ID: 30343520
[TBL] [Abstract][Full Text] [Related]
7. Cancer gene analysis of liquid-based cytology specimens using next-generation sequencing: A technical report of bimodal DNA- and RNA-based panel application.
Akahane T; Isochi-Yamaguchi T; Hashiba-Ohnuki N; Bandoh N; Aimono E; Kato Y; Nishihara H; Kamada H; Tanimoto A
Diagn Cytopathol; 2023 Aug; 51(8):493-500. PubMed ID: 37162026
[TBL] [Abstract][Full Text] [Related]
8. Using the DNA Integrity Number to Analyze DNA Quality in Specimens Collected from Liquid-Based Cytology after Fine-Needle Aspiration of Breast Tumors and Lesions.
Hoshino A; Oana Y; Ohi Y; Maeda Y; Omori M; Takada Y; Ikeda T; Sotome K; Maeda H; Yanagisawa T; Takeuchi O; Kuronuma S; Sangai T; Shibahara Y; Murakumo Y; Saegusa M; Kanomata N; Nagasawa S; Yamaguchi R; Yoshida M; Kozuka Y; Matsumoto H; Tsugawa K; Maeda I;
Acta Cytol; 2024; 68(2):145-152. PubMed ID: 38555634
[TBL] [Abstract][Full Text] [Related]
9. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.
Yokoyama S; Iwaya H; Akahane T; Hamada T; Higashi M; Hashimoto S; Tanoue S; Ohtsuka T; Ido A; Tanimoto A
Diagn Cytopathol; 2022 Nov; 50(11):499-507. PubMed ID: 36181430
[TBL] [Abstract][Full Text] [Related]
10. Optimal Preservations of Cytological Materials Using Liquid-Based Cytology Fixatives for Next-Generation Sequencing Analysis.
Tanaka R; Fujiwara M; Nakazato Y; Arai N; Tachibana K; Sakamoto N; Kishimoto K; Kamma H; Shibahara J; Kondo H
Acta Cytol; 2022; 66(5):457-465. PubMed ID: 35413709
[TBL] [Abstract][Full Text] [Related]
11. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the success of next-generation sequencing in cytology specimens.
Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
[TBL] [Abstract][Full Text] [Related]
13. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
14. Overview of Molecular Testing of Cytology Specimens.
Huang M; Wei S
Acta Cytol; 2020; 64(1-2):136-146. PubMed ID: 30917368
[TBL] [Abstract][Full Text] [Related]
15. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Validation of Cytology Specimens for Next-Generation Sequencing and Clinical Practice Experience.
Balla A; Hampel KJ; Sharma MK; Cottrell CE; Sidiropoulos N
J Mol Diagn; 2018 Nov; 20(6):812-821. PubMed ID: 29981866
[TBL] [Abstract][Full Text] [Related]
17. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
[TBL] [Abstract][Full Text] [Related]
18. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
19. Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology.
Amemiya K; Hirotsu Y; Oyama T; Omata M
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29630047
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing in cytology.
Pisapia P; Pepe F; Sgariglia R; Nacchio M; Russo G; Conticelli F; Girolami I; Eccher A; Bellevicine C; Vigliar E; Malapelle U; Troncone G
Cytopathology; 2021 Sep; 32(5):588-595. PubMed ID: 33792981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
